HEPATITIS B FOUNDATION

HEPATITIS B FOUNDATION

Doylestown, PA, US
501(c)3
EIN
23-2655669

HEPATITIS B FOUNDATION

Doylestown, PA, US
501(c)3
EIN
23-2655669

Income Statement

Fiscal Year Start:
Jul 1
Revenues in 2025

$3,466,580

Other
32%
Government Grants
21%
Contributions
20%
Program Services
20%
Fundraising Events
4%
Investments
3%
Membership Dues
0%
Expenses in 2025

$3,250,824

Salaries & Benefits
59%
Other
27%
Fees to Service Providers
9%
Grants
4%
Offices, Occupancy & IT
2%
Benefits to Members
0%
Advertising & Promotion
0%
Interest
0%
Depreciation
0%
Revenues
2024
2025
Change
Contributions
$932,473
$693,730
-26%
Government Grants
$733,257
$711,661
-3%
Fundraising Events
$121,121
$151,695
+25%
Program Services
$504,140
$684,246
+36%
Membership Dues
$0
$0
-
Investments
$106,160
$101,099
-5%
Other
$749,884
$1,124,149
+50%
Total Revenues
$3,147,035
$3,466,580
+10%
Expenses
2024
2025
Change
Grants
$157,715
$114,096
-28%
Benefits to Members
$0
$0
-
Salaries & Benefits
$1,667,779
$1,909,823
+15%
Fees to Service Providers
$268,349
$287,987
+7%
Advertising & Promotion
$0
$0
-
Offices, Occupancy & IT
$73,112
$53,470
-27%
Interest
$0
$0
-
Depreciation
$0
$0
-
Other
$931,181
$885,448
-5%
Total Expenses
$3,098,136
$3,250,824
+5%
Net income
2024
2025
Change
Net income
+$48,899
+$215,756
+341%
Functional Expenses
Summary
2024
2025
Change
Program
$2,419,977
$2,476,170
+2%
Admin
$203,312
$213,869
+5%
Fundraising
$474,847
$560,785
+18%
Total Expenses
$3,098,136
$3,250,824
+5%
Income Statement
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)